Anthony Bergmann - Net Worth and Insider Trading
Anthony Bergmann Net Worth
The estimated net worth of Anthony Bergmann is at least $2,858 dollars as of 2024-12-29. Anthony Bergmann is the Vice President of Finance of Capricor Therapeutics Inc and owns about 203 shares of Capricor Therapeutics Inc (CAPR) stock worth over $2,858. Details can be seen in Anthony Bergmann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anthony Bergmann has not made any transactions after 2016-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Anthony Bergmann
Anthony Bergmann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anthony Bergmann owns 1 companies in total, including Capricor Therapeutics Inc (CAPR) .
Click here to see the complete history of Anthony Bergmann’s form 4 insider trades.
Insider Ownership Summary of Anthony Bergmann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CAPR | Capricor Therapeutics Inc | 2020-02-12 | CHIEF FINANCIAL OFFICER |
Anthony Bergmann Latest Holdings Summary
Anthony Bergmann currently owns a total of 1 stock. Anthony Bergmann owns 203 shares of Capricor Therapeutics Inc (CAPR) as of March 16, 2016, with a value of $2,858.
Latest Holdings of Anthony Bergmann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CAPR | Capricor Therapeutics Inc | 2016-03-16 | 203 | 14.08 | 2,858 |
Holding Weightings of Anthony Bergmann
Anthony Bergmann Form 4 Trading Tracker
According to the SEC Form 4 filings, Anthony Bergmann has made a total of 0 transactions in Capricor Therapeutics Inc (CAPR) over the past 5 years. The most-recent trade in Capricor Therapeutics Inc is the acquisition of 203 shares on March 16, 2016, which cost Anthony Bergmann around $4,872.
Insider Trading History of Anthony Bergmann
- 1
Anthony Bergmann Trading Performance
GuruFocus tracks the stock performance after each of Anthony Bergmann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anthony Bergmann is 90%. GuruFocus also compares Anthony Bergmann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anthony Bergmann within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Anthony Bergmann's insider trading performs compared to the benchmark.
Performance of Anthony Bergmann
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 26.8 | | | | | |
| Relative Return to S&P 500(%) | 24.16 | | | | | |
Anthony Bergmann Ownership Network
Anthony Bergmann Owned Company Details
What does Capricor Therapeutics Inc do?
Who are the key executives at Capricor Therapeutics Inc?
Anthony Bergmann is the CHIEF FINANCIAL OFFICER of Capricor Therapeutics Inc. Other key executives at Capricor Therapeutics Inc include CHIEF BUSINESS OFFICER Xavier Avat , director & CHIEF EXECUTIVE OFFICER Linda Marban , and EVP & GENERAL COUNSEL Karen Krasney .
Capricor Therapeutics Inc (CAPR) Insider Trades Summary
Over the past 18 months, Anthony Bergmann made no insider transaction in Capricor Therapeutics Inc (CAPR). Other recent insider transactions involving Capricor Therapeutics Inc (CAPR) include a net purchase of 7,993 shares made by David B Musket , a net purchase of 2,798,507 shares made by , and a net purchase of 10,000 shares made by Collier Earl M Jr .
In summary, during the past 3 months, insiders sold 0 shares of Capricor Therapeutics Inc (CAPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Capricor Therapeutics Inc (CAPR) were sold and 2,821,500 shares were bought by its insiders, resulting in a net purchase of 2,821,500 shares.
Capricor Therapeutics Inc (CAPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Capricor Therapeutics Inc Insider Transactions
Anthony Bergmann Mailing Address
Above is the net worth, insider trading, and ownership report for Anthony Bergmann. You might contact Anthony Bergmann via mailing address: C/o Capricor Therapeutics, Inc., 8840 Wilshire Blvd., 2nd Floor, Beverly Hills Ca 90211.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
